C9h10n2o5 6h-Furo [II ', III, 4,5] Oxazolo [3,2-a] Pyrimidin-VI-unum, 2,3,3a, 2, 9a-TETRA-VI-Hydroxy-2- (Hydroxymethyl, III-Hydroxy-2R, 9a-TETRA-VI-Hydroxy-2R (Hydroxymethyl), Hydroxy-2R, 9a-TETRHA ydro-III-hydroxy-2r, 9a-TETRH-III-Hydroxy-2r, 9a-TETRH) - (2r, III R, 3as, 9ar) - (9c, 3as, 9ar) - (9c, 3s), 9AR) - (9c, 3as) - (9c, 3s), 9ar) - (9c, 3as)

Canonica ridet
O = C1n = C2oc3c (o) C (OC3N2C = C1) Co
Isomeric smiles
O [C @ h] I [C @] II ([C @] (N3C (O2) = NC (O.] = C.] (O [c @@] = [h] [h] [h] [h] c = c3), [c] c = c3), [h] c = c3), [c] c = c3), [h] c = c3), [c] c = =), [h] c = c3), [h] c = c3), [c] c = c3), [h] c = c3), [h] c = c3), [c] c = c3), [h] c = c3), [c] c = c3), [c] = c *), [= [c] [h] [h] c = c3), [c] c = =), [h] c = c3), [h] c = c3), [c] c = =), [c] [h],
INCHI
InChI= 1S/C9H10N2O5/c12-3-4-6(14)7-8(15-4)11-2-1-5(13)10-9(11)16-7/h1-2,4,6-8,12,14H,3H2/t4-,6-,7+,8-/m1/s1
Key Inchi
Uugitdaswnoagg, ccxzuqqusa, n
XIII aliis nominibus ad hanc substantiam
(2r, III r, 3as, 9ar) -2,3,3a, 9a-tetrahydro-III-hydroxy-2- (hydroxymethyl) -6h-0- [II ', III,': 4,5] -6zozolo, [III -6H], VI-[ACI); 6H-Foto [II, 'III, 4,5] Oxazolo [3,2-a] Pyimidin-VI, 2,3,3a, 9a-Tetrahydro-III-Hydroxy, 2- (hydroxymethyl) - (6ci, 7ci); 6H-Foto [II ', III, 4,5] Oxazolo [3,2-a] Pyimidin-VI, 2,3,3A, 2,β-Tetraxymethyl, III-hydroxy, 2r- (2α, 3aβ, 3Aβ, 9A (Hydroxymethyl, III, 3Aβ, 9Aβ)] - (Zci); 6H-Foto [II ', III, 4,5] Oxazolo [3,2-a]

Pyrimidin-VI-unus, 2,3,3a, 9a-Tetrahydro-III-hydroxy-2- (hydroxymethyl) -, stereoisomer (8ci); 2,2 '-Anhydro (1. β-Arabinofuranosyl) Uracil; 2,2 '-Anhydro-1. β-Arabino, Furanosyluracil; 2,2 '-Anhydro, N1- (β -D-Arabinofuranosyl) Uracil; 2,2, -Anhydrouridine; 2,2, -o-cyclouridine; NSC (CLVII) CXLVIII; O2,2 '-Anhydrouridine; O2,2 '-ccloystidine; β -D-II ', II-o-cycloarabinouridine